These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The prevalence and clinical significance of (18) F-2-fluoro-2-deoxy-D-glucose (FDG) uptake in the thyroid gland on PET or PET-CT in patients with lymphoma. Lin M, Wong C, Lin P, Shon IH, Cuganesan R, Som S. Hematol Oncol; 2011 Jun; 29(2):67-74. PubMed ID: 20635328 [Abstract] [Full Text] [Related]
13. The efficacy of whole-body FDG-PET or PET/CT for autoimmune pancreatitis and associated extrapancreatic autoimmune lesions. Nakajo M, Jinnouchi S, Fukukura Y, Tanabe H, Tateno R, Nakajo M. Eur J Nucl Med Mol Imaging; 2007 Dec; 34(12):2088-95. PubMed ID: 17713765 [Abstract] [Full Text] [Related]
14. Role of 2-[18F] fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in the post-therapy surveillance of breast cancer. Chang HT, Hu C, Chiu YL, Peng NJ, Liu RS. PLoS One; 2014 Dec; 9(12):e115127. PubMed ID: 25517451 [Abstract] [Full Text] [Related]
15. Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system. Schmidt H, Brendle C, Schraml C, Martirosian P, Bezrukov I, Hetzel J, Müller M, Sauter A, Claussen CD, Pfannenberg C, Schwenzer NF. Invest Radiol; 2013 May; 48(5):247-55. PubMed ID: 23519008 [Abstract] [Full Text] [Related]
20. Hyperaccumulation of (18)F-FDG in order to differentiate solid pseudopapillary tumors from adenocarcinomas and from neuroendocrine pancreatic tumors and review of the literature. Guan ZW, Xu BX, Wang RM, Sun L, Tian JH. Hell J Nucl Med; 2013 May; 16(2):97-102. PubMed ID: 23687644 [Abstract] [Full Text] [Related] Page: [Next] [New Search]